World
Stem Cell Crusader Sparks New Hope for Fighting Diabetes, Heart Disease
Regenerative medicine could be a $120 billion industry by 2030.
iPS cells derived from adult human dermal fibroblasts.
Photographer: Shinya Yamanaka, Center for iPS Cell Research and Application, Kyoto University